TRU-016
16011
Phase 1 small_molecule completed
Quick answer
TRU-016 for B-cell Small Lymphocytic Lymphoma Recurrent is a Phase 1 program (small_molecule) at Aptevo Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Aptevo Therapeutics
- Indication
- B-cell Small Lymphocytic Lymphoma Recurrent
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed